The Risk of Pneumonitis From Radiation in Patients With Lung Cancer
Laurie Gaspar, MD, Professor and Chair Department of Radiation Oncology, Grohne Chair in Clinical Oncology, University of Colorado School of Medicine, discusses the risk of pneumonitis from radiation among patients with lung cancer.
Laurie Gaspar, MD, Professor and Chair Department of Radiation Oncology, Grohne Chair in Clinical Oncology, University of Colorado School of Medicine, discusses the risk of pneumonitis from radiation among patients with lung cancer.
Clinical Pearls
Some large cooperative group studies claim that the risk of symptomatic radiation pneumonitis is small -- less than 10%. On an actuarial basis, Gaspar says, about 30-40% of patients experience pneumonitis at 1 year.Gaspar says this larger figure needs to be discussed with patients and physicians need to work on lowering the percentage. Most oncologists also agree that some side effects from radiation are being underestimated, Gaspar says
- Patients need to be more aware of the real risk of pneumonitis from radiation
Advancing Neoadjuvant Therapy for HER2+ Breast Cancer Through ctDNA Monitoring
December 19th 2024In an interview with Targeted Oncology, Adrienne Waks, MD, provided insights into the significance of the findings from the DAPHNe trial and their clinical implications for patients with HER2-positive breast cancer.
Read More
